on007865
NEMAR copy of ds007865
You're viewing the NEMAR copy at v1.0.0.
Each OpenNeuro pull is a NEMAR major bump
(vN.0.0); intermediate versions are NEMAR-side fixes.
NEMAR DOI 10.82901/nemar.on007865
OpenNeuro DOI 10.18112/openneuro.ds007865.v1.0.0
Placebo Neuroepo multisession Phase II and III
Multisession EEG dataset from a randomized, placebo-controlled study of intranasal NeuroEPO (erythropoietin-derived formulation) in patients with Parkinson's disease. Clinical (MDS-UPDRS III) and EEG assessments were acquired at baseline and 9 months after completing the intervention. Cumulative NeuroEPO dose is coded per participant (placebo = 0), enabling analysis of treatment effects on brain activity.
EEG